BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1049 related articles for article (PubMed ID: 22309967)

  • 1. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombotic microangiopathies].
    Nielsen OJ; Friis-Hansen L
    Ugeskr Laeger; 2009 Nov; 171(49):3614-20. PubMed ID: 19954703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating TTP/HUS with plasma exchange: a single centre's 25-year experience.
    Forzley BR; Sontrop JM; Macnab JJ; Chen S; Clark WF
    Br J Haematol; 2008 Oct; 143(1):100-6. PubMed ID: 18691172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombotic microangiopathy: when time is the key factor!].
    Hemett OM; Martins F; Descombes E; Betticher D; Hayoz D
    Rev Med Suisse; 2014 Apr; 10(425):794, 796-803. PubMed ID: 24791425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and Secondary Thrombotic Microangiopathy Referred to a Single Plasma Exchange Center for Suspected Thrombotic Thrombocytopenic Purpura: 2000-2011.
    Dahlan R; Sontrop JM; Li L; Ghadieh O; Clark WF
    Am J Nephrol; 2015; 41(6):429-37. PubMed ID: 26183258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
    Bosch T; Wendler T
    Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L
    Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attending rounds: microangiopathic hemolytic anemia with renal insufficiency.
    Clark WF; Hildebrand A
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):342-7. PubMed ID: 22193233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
    Bell WR; Braine HG; Ness PM; Kickler TS
    N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H; Matsumoto T; Yamashita Y
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathies (TTP, HUS, HELLP).
    Kappler S; Ronan-Bentle S; Graham A
    Emerg Med Clin North Am; 2014 Aug; 32(3):649-71. PubMed ID: 25060255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study.
    Zhang W; Shi H; Ren H; Shen PY; Pan XX; Li X; Chen YX; Xu YW; Chen XN; Zhu P; Chen N
    Nephron Clin Pract; 2009; 112(3):c177-83. PubMed ID: 19439988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Hayward CP; Sutton DM; Carter WH; Campbell ED; Scott JG; Francombe WH; Shumak KH; Baker MA
    Arch Intern Med; 1994 May; 154(9):982-7. PubMed ID: 8179455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.